# A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors.

> **NCT05396339** · PHASE1,PHASE2 · UNKNOWN · sponsor: **SUNHO（China）BioPharmaceutical CO., Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Advanced Malignant Solid Tumor

## Interventions

- **DRUG:** IAE0972

## Key facts

- **NCT ID:** NCT05396339
- **Lead sponsor:** SUNHO（China）BioPharmaceutical CO., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-24
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05396339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05396339, "A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05396339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*